RE: What other aim company20 Nov 2019 09:22
Recent placing to fund the next 12 months:
1.support from new and existing shareholders, employees and Company directors
2. a significant number of new Nordic shareholders.
3. Funding will further progress Clevegen to clarifying its full potential, either alone or in combination with existing cancer treatments.
4. Any new information on clevegen specifys FARNs goals for the ongoing partnering discussions.